Home  >  Products  >  LAPTM4B (lysosomal associated protein transmembrane 4 beta) Blocking Peptide (the middle region of protein) (100ug)
LAPTM4B (lysosomal associated protein transmembrane 4 beta) Blocking Peptide (the middle region of protein) (100ug)

LAPTM4B (lysosomal associated protein transmembrane 4 beta) Blocking Peptide (the middle region of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LAPTM4B antibody (Catalogue #: ARP47442_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP47442
Size: 100 ug
Weight: 35kDa
Gene: 55353
Format: Lyophilized powder
Target: LAPTM4B is a multi-pass membrane protein. It belongs to the LAPTM4/LAPTM5 transporter family. LAPTM4b has active role in disease progression of malignant cells and is involved in cell proliferation and multidrug resistance. The genetic polymorphism of LAPTM4B is a potential risk factor for the development of colon cancer and gastric cancer. The research results also indicated that LAPTM4B may be a clinically useful prognostic indicator for ovarian carcinoma and may play a role in human hepatocellular carcinoma.
Alternative names: LAPTM4beta; LC27
See Full Product Listings >